NAPROXEN
- Product NDC
- 68071-4006
- 11-digit product format
- 680714006
- Labeler code
- 68071
- Product ID
- 68071-4006_1d7a3c9a-73d5-5360-e063-6394a90aa3e6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NAPROXEN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA091416
- Marketing category
- ANDA
- Marketing start
- 2016-07-06
- Substance
- NAPROXEN
- Active strength
- 500 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091416-001 | NAPROXEN | NAPROXEN | 250MG | TABLET / ORAL | AB | 2011-02-14 | |
| A091416-002 | NAPROXEN | NAPROXEN | 375MG | TABLET / ORAL | AB | 2011-02-14 | |
| A091416-003 | NAPROXEN | NAPROXEN | 500MG | TABLET / ORAL | AB | 2011-02-14 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A091416-001 | AB |
| A091416-002 | AB |
| A091416-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A091416-001 | NAPROXEN | 250MG | TABLET / ORAL | AB | 2011-02-14 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A091416-002 | NAPROXEN | 375MG | TABLET / ORAL | AB | 2011-02-14 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A091416-003 | NAPROXEN | 500MG | TABLET / ORAL | AB | 2011-02-14 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A091416-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A091416-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A091416-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NAPROXEN | NAPROXEN | Northwind Health Company, LLC | f32d755e-4984-ee40-e053-2995a90a4ebe | 2026-01-01 | Warnings | 091416 ANDA091416 |
| NAPROXEN | NAPROXEN | QPharma Inc | c0a4839b-7154-c82c-e053-2a95a90a7e6d | 2025-12-03 | Warnings | 091416 ANDA091416 |
| NAPROXEN | NAPROXEN | PD-Rx Pharmaceuticals, Inc. | a9f9ce81-9d51-4167-9581-974866a8fe31 | 2025-10-17 | Warnings | 091416 ANDA091416 |
| NAPROXEN | NAPROXEN | DIRECT RX | b1b78c49-82e9-2402-e053-2a95a90ae35f | 2025-01-17 | Warnings | 091416 ANDA091416 |
| Naproxen | NAPROXEN | Advanced Rx of Tennessee, LLC | af9a96cf-1cda-8ace-e053-2a95a90a18cc | 2024-12-31 | Boxed warning, Warnings, Adverse reactions | 091416 ANDA091416 |
| Naproxen | NAPROXEN | MARKSANS PHARMA LIMITED | 1fdb4cbd-e9e8-47bb-b3d8-1f1ec8f411c8 | 2024-12-02 | Boxed warning, Warnings, Adverse reactions | 091416 ANDA091416 |
| NAPROXEN | NAPROXEN | NuCare Pharmaceuticals,Inc. | 5487dee2-5c37-4348-e054-00144ff8d46c | 2024-07-17 | Warnings | 091416 ANDA091416 68071-4006 |
| NAPROXEN | NAPROXEN | NuCare Pharmaceuticals,Inc. | 71d4a048-ca50-73db-e053-2a95a90ad465 | 2024-06-10 | Warnings | 091416 ANDA091416 |
| NAPROXEN | NAPROXEN | NuCare Pharmaceuticals,Inc. | 69366b55-2687-17a4-e053-2a91aa0a65b3 | 2024-06-07 | 091416 ANDA091416 | |
| NAPROXEN | NAPROXEN | Asclemed USA, Inc. | a4fcb411-c918-459b-adc6-06dfa8ed8a50 | 2022-10-12 | Warnings | 091416 ANDA091416 |
| NAPROXEN | NAPROXEN | Aphena Pharma Solutions - Tennessee, LLC | 32693390-763b-46dd-b821-65a7bf3c6671 | 2021-04-26 | Warnings | 091416 ANDA091416 |
| NAPROXEN | NAPROXEN | Bryant Ranch Prepack | 5d399bf3-db49-411a-91b9-b410d702a65a | 2020-12-14 | Warnings | 091416 ANDA091416 |
| NAPROXEN | NAPROXEN | TIME CAP LABORATORIES | 4350a2d9-5228-460e-b7b1-27e8fa846787 | 2018-10-09 | Warnings | 091416 ANDA091416 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- NAPROXEN
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| NAPROXEN | 500 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 57Y76R9ATQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 198014 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 5487dee2-5c37-4348-e054-00144ff8d46c | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fef6ad89-235f-4274-ba49-a8e53642473e | Product name | 2 | 20250225 |
| 87fed3e6-8fba-48ef-96b0-3a7fb54b96ff | Product name | 3 | 20230306 |
| b5fdaaec-7251-4da6-9cb2-4e9e76939ec8 | Product name | 1 | 20200623 |
| e76dbbc1-775d-722c-08ff-ed45e8a80def | Product name | 3 | 20181002 |
| 6f4f4521-fd56-1ae6-888b-3b021bd75c7c | Product name | 1 | 20140508 |
| ce67e27d-1d21-5465-4409-b0662dd99d4d | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-4006-1 | NAPROXEN | 10 in 1 BOTTLE | TABLET | 10 | 5 | |
| 68071-4006-2 | NAPROXEN | 20 in 1 BOTTLE | TABLET | 20 | 5 | |
| 68071-4006-3 | NAPROXEN | 30 in 1 BOTTLE | TABLET | 30 | 5 | |
| 68071-4006-4 | NAPROXEN | 40 in 1 BOTTLE | TABLET | 40 | 5 | |
| 68071-4006-5 | NAPROXEN | 15 in 1 BOTTLE | TABLET | 15 | 5 | |
| 68071-4006-6 | NAPROXEN | 60 in 1 BOTTLE | TABLET | 60 | 5 | |
| 68071-4006-7 | NAPROXEN | 14 in 1 BOTTLE | TABLET | 14 | 5 | |
| 68071-4006-9 | NAPROXEN | 90 in 1 BOTTLE | TABLET | 90 | 5 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68071-4006-3 | EA - Each | 68071-4006 | 1ad25a3c-fb8a-4643-81d1-eaf0f866a405 | 1 | 2019-12-10 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-4006 | NAPROXEN TABLET [NUCARE PHARMACEUTICALS,INC.] | 5 | Current NDC, Legacy NDC, 8 package rows | 20240719_5487dee2-5c37-4348-e054-00144ff8d46c.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 198014 | naproxen 500 MG Oral Tablet | PSN | 5487dee2-5c37-4348-e054-00144ff8d46c | 5 |
| 198014 | naproxen 500 MG Oral Tablet | SCD | 5487dee2-5c37-4348-e054-00144ff8d46c | 5 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68071-4006-1 | 68071400601 | 10 TABLET in 1 BOTTLE (68071-4006-1) | 10 tablet | 2017-07-17 | 0000-00-00 | No | No | Current |
| 68071-4006-2 | 68071400602 | 20 TABLET in 1 BOTTLE (68071-4006-2) | 20 tablet | 2017-07-17 | 0000-00-00 | No | No | Current |
| 68071-4006-3 | 68071400603 | 30 TABLET in 1 BOTTLE (68071-4006-3) | 30 tablet | 2017-07-17 | 0000-00-00 | No | No | Current |
| 68071-4006-4 | 68071400604 | 40 TABLET in 1 BOTTLE (68071-4006-4) | 40 tablet | 2017-07-17 | 0000-00-00 | No | No | Current |
| 68071-4006-5 | 68071400605 | 15 TABLET in 1 BOTTLE (68071-4006-5) | 15 tablet | 2017-07-17 | 0000-00-00 | No | No | Current |
| 68071-4006-6 | 68071400606 | 60 TABLET in 1 BOTTLE (68071-4006-6) | 60 tablet | 2017-07-17 | 0000-00-00 | No | No | Current |
| 68071-4006-7 | 68071400607 | 14 TABLET in 1 BOTTLE (68071-4006-7) | 14 tablet | 2017-07-17 | 0000-00-00 | No | No | Current |
| 68071-4006-9 | 68071400609 | 90 TABLET in 1 BOTTLE (68071-4006-9) | 90 tablet | 2017-07-17 | 0000-00-00 | No | No | Current |